Lantheus Holdings, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends

SG&A Expense Trends: A Tale of Two Companies

In the competitive landscape of healthcare, understanding the financial strategies of key players is crucial. Over the past decade, Bausch Health Companies Inc. and Lantheus Holdings, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Bausch Health, with a consistent annual SG&A expense averaging around $2.57 billion, reflects a stable yet high-cost operational strategy. In contrast, Lantheus Holdings has demonstrated a more dynamic growth, with SG&A expenses increasing by approximately 270% from 2014 to 2023. This suggests a strategic expansion and investment in administrative capabilities. Notably, 2023 marked a peak for both companies, with Bausch Health reaching nearly $2.92 billion and Lantheus Holdings climbing to $267 million. These trends highlight the differing approaches to growth and cost management in the healthcare sector, offering valuable insights for investors and industry analysts alike.